375 results
Page 8 of 19
8-K
EX-99.1
yzg5ctmn
22 Apr 14
Breo™Ellipta® (fluticasone furoate/vilanterol trifenatate) approved in Australia for Asthma and Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-10.4
aiocn73ly92dg23b
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.3
mqzy mvlhezbw0lihb9
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.5
l58mz6v0cg7
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.1
18y16
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-99.1
lmyywb nhnxagp6lazq0
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-99.1
kaercclef56oamj8u2d9
9 Apr 14
Regulation FD Disclosure
12:00am
8-K
EX-99
0ios8wupa138t417bqnf
13 Mar 14
Other Events
12:00am
8-K
EX-99
xpyk5322l 4slgil9ry7
6 Feb 14
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
263837patx tju
9 Jan 14
ANORO™ ELLIPTA™ approved for COPD treatment in Canada
12:00am
8-K
EX-99.1
di34l5olo8frsqxv
8 Jan 14
Other Events
12:00am
8-K
EX-99.1
uwtxut93
18 Dec 13
Other Events
12:00am
8-K
EX-99
21axhy1vnc savk3
6 Dec 13
Other Events
12:00am
8-K
EX-99
qwty8hbbx8
30 Oct 13
Other Events
12:00am
8-K
EX-99
pcxfi 55m97
20 Sep 13
Other Events
12:00am
8-K
EX-99
2c105q9fd5q ywm
19 Sep 13
Regulation FD Disclosure
12:00am